GlassScriptPhysician profile
Gaurav Bharti
NPI 1477733053
$526,889.94
in general payments reported to CMS, 2019-2025
24 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163K · 2020: $58K · 2021: $79K · 2022: $41K · 2023: $81K · 2024: $36K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125K · Consulting Fee: $34K · Travel and Lodging: $16K · Food and Beverage: $10K · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125,014.08 |
| Consulting Fee | $34,073.45 |
| Travel and Lodging | $15,646.65 |
| Food and Beverage | $10,071.95 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $331,290.09 | 2019-2022 | |
| Abbvie INC. | $162,173.90 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Revolve |
| Motiva USA, LLC | $18,924.01 | 2024-2025 | |
| Sientra, INC. | $4,343.15 | 2019-2022 | |
| Davol INC. | $2,657.45 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip |
| Galderma Laboratories, L.P. | $2,551.11 | 2019-2025 | Dysport |
| Tepha INC | $1,864.83 | 2019-2020 | |
| Sealonix INC. | $909.40 | 2024 | |
| Bard Peripheral Vascular, INC. | $645.22 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $361.41 | 2019-2023 | |
| Merz North America, INC. | $236.07 | 2023 | Xeomin |
| Revance Therapeutics, INC. | $183.16 | 2025 | Daxxify |
| Endo Pharmaceuticals INC. | $142.41 | 2019 | |
| Dilon Technologies, INC. | $103.61 | 2023-2025 | Hemoblast Bellows |
| Mentor Worldwide LLC | $99.13 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $64.02 | 2020 | |
| Sensus Healthcare, INC. | $61.66 | 2021 | |
| Tela Bio, INC. | $56.31 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Solta Medical, A Division of Bausch Health US, LLC | $44.80 | 2022-2025 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $43.75 | 2019 | |
| Ethicon US, LLC | $37.40 | 2024 | Stratafix |
| Integra Lifesciences Corporation | $36.51 | 2023-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Becton, Dickinson and Company | $32.28 | 2024 | |
| Biom'Up France Sas | $28.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Bharti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.